ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2019

DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use.

Maximilian Klingler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.